X4 PHARMACEUTICALS, INC Increase (Decrease) in Prepaid Expense and Other Assets
X4 PHARMACEUTICALS, INC (XFOR) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $3.02M.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$778.00K.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$3.39M, a 758.75% decline year-over-year.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$421.00K, a 309.45% decline year-over-year.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$4.25M.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$683.00K, a 149.85% decline from fiscal 2023.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.37M, a 124.59% increase from fiscal 2022.
- X4 PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2022 was $610.00K, a 65.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.24M 10-Q · filed 2026-08-06 | -$1.15M derived: sum of 3 quarters · filed 2026-08-06 | -$1.57M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$778.00K 10-Q · filed 2026-05-06 | -$4.16M derived: sum of 2 quarters · filed 2026-05-06 | -$4.58M derived: sum of 3 quarters · filed 2026-05-06 | -$4.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$3.81M derived: sum of 2 quarters · filed 2026-03-17 | -$4.05M derived: sum of 3 quarters · filed 2026-08-06 | -$4.25M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | -$421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$661.00K derived: sum of 2 quarters · filed 2026-08-06 | -$862.00K 10-Q · filed 2025-11-05 | -$348.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$441.00K 10-Q · filed 2026-08-06 | $73.00K derived: sum of 3 quarters · filed 2026-08-06 | $274.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$201.00K 10-Q · filed 2026-05-06 | $313.00K derived: sum of 2 quarters · filed 2026-05-06 | $514.00K derived: sum of 3 quarters · filed 2026-05-06 | $178.00K derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $715.00K derived: sum of 2 quarters · filed 2026-03-17 | $379.00K derived: sum of 3 quarters · filed 2026-03-17 | -$683.00K 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$135.00K derived: sum of 2 quarters · filed 2025-11-05 | -$1.20M 10-Q · filed 2025-11-05 | $632.00K derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-06-30 | -$336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.40M 10-Q · filed 2025-08-08 | $431.00K derived: sum of 3 quarters · filed 2026-03-17 | $451.00K derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2024-03-31 | -$1.06M 10-Q · filed 2025-05-01 | $767.00K derived: sum of 2 quarters · filed 2026-03-17 | $787.00K derived: sum of 3 quarters · filed 2026-03-17 | $2.39M derived: sum of 4 quarters · filed 2026-03-17 | ||||
| 2023-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.85M derived: sum of 2 quarters · filed 2026-03-17 | $3.45M derived: sum of 3 quarters · filed 2026-03-17 | $1.37M 10-K · filed 2026-03-17 | ||||
| 2023-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.63M derived: sum of 2 quarters · filed 2024-11-13 | -$459.00K 10-Q · filed 2024-11-13 | $309.00K derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$479.00K 10-Q · filed 2024-08-08 | $289.00K derived: sum of 3 quarters · filed 2025-03-26 | $952.00K derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2023-03-31 | -$2.08M 10-Q · filed 2024-05-07 | -$1.32M derived: sum of 2 quarters · filed 2025-03-26 | -$653.00K derived: sum of 3 quarters · filed 2025-03-26 | $159.00K derived: sum of 4 quarters · filed 2025-03-26 | ||||
| 2022-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.43M derived: sum of 2 quarters · filed 2025-03-26 | $2.24M derived: sum of 3 quarters · filed 2025-03-26 | $610.00K 10-K · filed 2025-03-26 | ||||
| 2022-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.48M derived: sum of 2 quarters · filed 2023-11-09 | -$158.00K 10-Q · filed 2023-11-09 | $1.58M derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-06-30 | $812.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$821.00K 10-Q · filed 2023-08-10 | $920.00K derived: sum of 3 quarters · filed 2024-03-21 | -$954.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2022-03-31 | -$1.63M 10-Q · filed 2023-05-04 | $108.00K derived: sum of 2 quarters · filed 2024-03-21 | -$1.77M derived: sum of 3 quarters · filed 2024-03-21 | -$589.00K derived: sum of 4 quarters · filed 2024-03-21 | ||||
| 2021-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$133.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.04M derived: sum of 3 quarters · filed 2024-03-21 | $1.75M 10-K · filed 2024-03-21 | ||||
| 2021-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$697.00K derived: sum of 2 quarters · filed 2022-11-03 | $14.00K 10-Q · filed 2022-11-03 | -$751.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.89M 10-Q · filed 2022-08-04 | $1.12M derived: sum of 3 quarters · filed 2023-03-21 | -$658.00K derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2021-03-31 | $711.00K 10-Q · filed 2022-05-12 | -$54.00K derived: sum of 2 quarters · filed 2023-03-21 | -$1.83M derived: sum of 3 quarters · filed 2023-03-21 | $1.50M derived: sum of 4 quarters · filed 2023-03-21 | ||||
| 2020-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | -$2.55M derived: sum of 2 quarters · filed 2023-03-21 | $786.00K derived: sum of 3 quarters · filed 2023-03-21 | $1.66M 10-K · filed 2023-03-21 | ||||
| 2020-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.55M derived: sum of 2 quarters · filed 2021-11-04 | $2.42M 10-Q · filed 2021-11-04 | $2.60M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-06-30 | $3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $4.20M 10-Q · filed 2021-08-03 | $4.38M derived: sum of 3 quarters · filed 2022-03-17 | $4.11M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-03-31 | $869.00K 10-Q · filed 2021-05-06 | $1.05M derived: sum of 2 quarters · filed 2022-03-17 | $773.00K derived: sum of 3 quarters · filed 2022-03-17 | $165.00K derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2019-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$96.00K derived: sum of 2 quarters · filed 2022-03-17 | -$704.00K derived: sum of 3 quarters · filed 2022-03-17 | -$109.00K 10-K · filed 2022-03-17 | ||||
| 2019-09-30 | -$277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$885.00K derived: sum of 2 quarters · filed 2020-11-05 | -$290.00K 10-Q · filed 2020-11-05 | $62.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-06-30 | -$608.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$13.00K 10-Q · filed 2020-08-04 | $339.00K derived: sum of 3 quarters · filed 2021-03-19 | $198.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2019-03-31 | $595.00K 10-Q · filed 2020-05-07 | $947.00K derived: sum of 2 quarters · filed 2021-03-19 | $806.00K derived: sum of 3 quarters · filed 2021-03-19 | $486.00K derived: sum of 4 quarters · filed 2021-03-19 | ||||
| 2018-12-31 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $211.00K derived: sum of 2 quarters · filed 2021-03-19 | -$109.00K derived: sum of 3 quarters · filed 2021-03-19 | -$279.00K 10-K · filed 2021-03-19 | -$612.00K 10-K · filed 2019-03-11 | |||
| 2018-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$461.00K derived: sum of 2 quarters · filed 2019-11-07 | -$631.00K 10-Q · filed 2019-11-07 | -$721.00K 10-Q · filed 2018-11-09 | -$75.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$490.00K 10-Q · filed 2019-08-07 | $2.39M 10-Q · filed 2018-08-13 | $66.00K derived: sum of 3 quarters · filed 2020-03-12 | -$2.60M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | -$170.00K 10-Q · filed 2019-05-15 | $465.00K 10-Q · filed 2018-05-10 | $386.00K derived: sum of 2 quarters · filed 2020-03-12 | -$2.28M derived: sum of 3 quarters · filed 2020-03-12 | -$2.52M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | $556.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$2.11M derived: sum of 2 quarters · filed 2020-03-12 | -$2.35M derived: sum of 3 quarters · filed 2020-03-12 | -$402.00K 10-K · filed 2020-03-12 | -$284.00K 10-K · filed 2019-03-11 | |||
| 2017-09-30 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$2.91M derived: sum of 2 quarters · filed 2018-11-09 | -$958.00K 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $1.71M 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | $1.95M 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | $2.22M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |